tiprankstipranks
Mereo Biopharma Group Plc (MREO)
NASDAQ:MREO
Holding MREO?
Track your performance easily

Mereo Biopharma Group Plc (MREO) Financial Statements

575 Followers

Mereo Biopharma Group Plc Financial Overview

Mereo Biopharma Group Plc's market cap is currently ―. The company's EPS TTM is $-0.25; its P/E ratio is -14.32; Mereo Biopharma Group Plc is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 56.33M£ 94.30M£ 110.09M£ 23.47M£ 56.82M
Total Assets£ 88.08M£ 126.42M£ 144.92M£ 62.95M£ 109.78M
Total Debt£ 12.77M£ 16.76M£ 20.61M£ 17.94M£ 39.82M
Net Debt£ -43.56M£ -77.54M£ -89.49M£ -5.53M£ -17.00M
Total Liabilities£ 26.21M£ 38.41M£ 64.24M£ 77.92M£ 85.54M
Stockholders Equity£ 61.87M£ 88.00M£ 80.68M£ -14.97M£ 24.24M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Mereo Biopharma Group Plc Earnings and Revenue History

Mereo Biopharma Group Plc Debt to Assets

Mereo Biopharma Group Plc Cash Flow

Mereo Biopharma Group Plc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis